)
Visual22 Oct 2025
Epiroc's cash spent on M&A
Alembic Pharmaceuticals (APLLTD) investor relations material
Alembic Pharmaceuticals Q1 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 25/26 earnings summary5 Aug, 2025
Executive summary
Q1 FY26 consolidated revenue grew 10% year-over-year to INR 1,711 crores, with net profit up 15% to INR 154 crores and EBITDA up 20% to INR 288 crores, reflecting strong operational performance despite US generics and API pricing pressure.
India Branded Business, US Generics, and Ex-US Generics segments posted double-digit growth, while API business remained flat due to price erosion.
Gross margin improved to 76.2% from 74.8% year-over-year, aided by product mix and cost initiatives.
Strategic tech initiatives, including iPad-based engagement, Salesforce CRM, and AI-powered support, are enhancing competitiveness and productivity.
EPS for the quarter was INR 7.85, up from INR 6.84 last year.
Financial highlights
EBITDA margin improved to 17% in Q1 FY26 from 15% a year ago; net profit margin reached 9%.
R&D expenses increased 26% year-over-year to INR 145 crores, now at 8% of revenue.
Profit before tax grew 21% to INR 191 crores.
Working capital remained stable; better collections offset by higher inventory.
Debt-equity ratio (consolidated) increased to 0.22 from 0.12 year-over-year.
Outlook and guidance
R&D spend for FY26 guided at INR 600–650 crores.
Pipeline includes 15+ product launches in the US expected in FY26, with new facilities contributing to future growth.
India business expects to return to double-digit growth within months.
ROW (Rest of World) business expected to grow at least 15% for the year.
Effective tax rate for the year guided at 17–18%.
What is driving the lower debtor turnover ratio?
Explain the variance in Sikkim flood insurance.
Comment on non-operational entities dissolution.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Alembic Pharmaceuticals earnings date
Q2 25/266 Nov, 2025
Next Alembic Pharmaceuticals earnings date
Q2 25/266 Nov, 2025
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Alembic Pharmaceuticals Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of generic and specialty medicines. The company produces active pharmaceutical ingredients (APIs) and formulations across various therapeutic areas, including cardiology, dermatology, neurology, and anti-infectives. The company is headquartered in Vadodara, India, and its shares are listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE).
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage